Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 13 studies | 54% ± 25% | |
oligodendrocyte precursor cell | 11 studies | 50% ± 14% | |
GABAergic neuron | 10 studies | 50% ± 27% | |
astrocyte | 7 studies | 43% ± 21% | |
oligodendrocyte | 6 studies | 32% ± 17% | |
interneuron | 6 studies | 46% ± 24% | |
retina horizontal cell | 6 studies | 49% ± 23% | |
neuron | 5 studies | 27% ± 11% | |
retinal ganglion cell | 5 studies | 53% ± 21% | |
GABAergic interneuron | 3 studies | 42% ± 11% | |
GABAergic amacrine cell | 3 studies | 41% ± 21% | |
Mueller cell | 3 studies | 41% ± 7% | |
glycinergic amacrine cell | 3 studies | 46% ± 24% | |
granule cell | 3 studies | 60% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 34% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 3751.60 | 2563 / 2642 | 99% | 25.10 | 699 / 705 |
adrenal gland | 9% | 48.29 | 23 / 258 | 74% | 17.36 | 170 / 230 |
prostate | 3% | 10.54 | 7 / 245 | 63% | 3.77 | 314 / 502 |
skin | 1% | 2.75 | 15 / 1809 | 62% | 4.13 | 294 / 472 |
esophagus | 0% | 0 | 0 / 1445 | 60% | 2.46 | 109 / 183 |
ovary | 0% | 0 | 0 / 180 | 45% | 1.48 | 195 / 430 |
liver | 0% | 0 | 0 / 226 | 43% | 1.09 | 175 / 406 |
lung | 3% | 7.86 | 15 / 578 | 38% | 1.19 | 442 / 1155 |
stomach | 1% | 1.65 | 2 / 359 | 29% | 1.06 | 82 / 286 |
pancreas | 0% | 0.89 | 1 / 328 | 27% | 0.69 | 48 / 178 |
bladder | 0% | 0 | 0 / 21 | 27% | 0.84 | 137 / 504 |
breast | 0% | 0 | 0 / 459 | 27% | 1.12 | 299 / 1118 |
uterus | 0% | 0 | 0 / 170 | 25% | 0.81 | 114 / 459 |
intestine | 2% | 4.33 | 15 / 966 | 23% | 0.56 | 120 / 527 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.55 | 6 / 29 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.47 | 8 / 45 |
thymus | 1% | 3.88 | 9 / 653 | 14% | 0.53 | 87 / 605 |
eye | 0% | 0 | 0 / 0 | 5% | 0.19 | 4 / 80 |
kidney | 0% | 0 | 0 / 89 | 2% | 0.07 | 21 / 901 |
adipose | 0% | 1.17 | 5 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001956 | Biological process | positive regulation of neurotransmitter secretion |
GO_0007420 | Biological process | brain development |
GO_0050890 | Biological process | cognition |
GO_0050807 | Biological process | regulation of synapse organization |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0008277 | Biological process | regulation of G protein-coupled receptor signaling pathway |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0042995 | Cellular component | cell projection |
GO_0005886 | Cellular component | plasma membrane |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0005634 | Cellular component | nucleus |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0008047 | Molecular function | enzyme activator activity |
GO_0160079 | Molecular function | G protein-coupled glycine receptor activity |
Gene name | GPR158 |
Protein name | G protein-coupled receptor 158 Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158) |
Synonyms | KIAA1136 |
Description | FUNCTION: Metabotropic receptor for glycine that controls synapse formation and function in the brain . Acts as an atypical G-protein coupled receptor that recruits and regulates the RGS7-GNB5 complex instead of activating G proteins . In absence of glycine ligand, promotes the GTPase activator activity of RGS7, increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form . Glycine-binding changes the conformation of the intracellular surface, inhibiting the GTPase activator activity of the RGS7-GNB5 complex, promoting G protein alpha subunits into their active GTP-bound form and regulating cAMP levels . Also able to bind taurine, a compound closely related to glycine, but with a two-fold lower affinity . Glycine receptor-dependent regulation of cAMP controls key ion channels, kinases and neurotrophic factors involved in neuronal excitability and synaptic transmission . Plays a pivotal role in regulating mood and cognition via its ability to regulate neuronal excitability in L2/L3 pyramidal neurons of the prefrontal cortex (By similarity). Also involved in spatial learning by regulating hippocampal CA1 neuronal excitability (By similarity). Acts as a synaptic organizer in the hippocampus, required for proper mossy fiber-CA3 neurocircuitry establishment, structure and function: induces presynaptic differentiation in contacting axons via its interaction with GPC4 (By similarity). In addition to glycine, may also act as a receptor for osteocalcin (BGLAP) hormone: osteocalcin-binding initiates a signaling response that prevents neuronal apoptosis in the hippocampus and regulates the synthesis of neurotransmitters (By similarity). . |
Accessions | ENST00000650135.1 A0A3B3IUC3 Q5T848 ENST00000376351.4 |